AWS Generative AI Innovation Pharmaceuticals 
AWS Machine Learning - AI
MARCH 4, 2024
Amazon Bedrock is the best place to build and scale generative AI applications with large language models (LLM) and other foundation models (FMs). It enables customers to leverage a variety of high-performing FMs, such as the Claude family of models by Anthropic, to build custom generative AI applications.
AWS Machine Learning - AI
FEBRUARY 6, 2024
Bringing innovative new pharmaceuticals drugs to market is a long and stringent process. Accenture built a regulatory document authoring solution using automated generative AI that enables researchers and testers to produce CTDs efficiently. AI delivers a major leap forward.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CIO
DECEMBER 18, 2023
Over the summer, I wrote a column about how CIOs are worried about the informal rise of generative AI in the enterprise. Since then, many CIOs I’ve spoken with have grappled with enterprise data security and privacy issues around AI usage in their companies. That column may have been the understatement of the year.
Existek
OCTOBER 18, 2023
In this article, we’ll discuss the topic of generative AI in healthcare and how it’s transforming this vital industry. List of the Content What is generative AI? How is generative AI transforming healthcare? Challenges of generative AI in healthcare Conclusion WHAT IS GENERATIVE AI?
CIO
APRIL 4, 2024
Some prospective projects require custom development using large language models (LLMs), but others simply require flipping a switch to turn on new AI capabilities in enterprise software. “AI For example, it’s experimenting with using gen AI to automatically read financial statements from corporate customers when assessing loan applications.
CIO
JANUARY 3, 2024
Other respondents said they aren’t using any generative AI models, are building their own, or are using an open-source alternative. Synthetic media, which includes AI-generated text, images, audio, and video, grew by 222% compared to the previous year. And the AI writing assistant category grew by 177%.
CIO
DECEMBER 14, 2023
Caveat emptor in the cloud Bob McGowan, CIO of Regeneron Pharmaceuticals, acknowledges the risk of cloud concentration is valid but he is more concerned about the readiness of SaaS partners. “If It is no longer a decision between AWS and Azure. As for the AI question, this CIO’s approach mirrors that of many CIOs today. “We
Expert insights. Personalized for you.
134 
Let's personalize your content